1. Home
  2. PACB vs CTO Comparison

PACB vs CTO Comparison

Compare PACB & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • CTO
  • Stock Information
  • Founded
  • PACB 2000
  • CTO 1902
  • Country
  • PACB United States
  • CTO United States
  • Employees
  • PACB N/A
  • CTO N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • CTO Real Estate Investment Trusts
  • Sector
  • PACB Industrials
  • CTO Real Estate
  • Exchange
  • PACB Nasdaq
  • CTO Nasdaq
  • Market Cap
  • PACB 462.1M
  • CTO 538.9M
  • IPO Year
  • PACB 2010
  • CTO N/A
  • Fundamental
  • Price
  • PACB $1.32
  • CTO $16.42
  • Analyst Decision
  • PACB Buy
  • CTO Strong Buy
  • Analyst Count
  • PACB 9
  • CTO 3
  • Target Price
  • PACB $2.06
  • CTO $22.00
  • AVG Volume (30 Days)
  • PACB 7.4M
  • CTO 295.9K
  • Earning Date
  • PACB 08-07-2025
  • CTO 07-29-2025
  • Dividend Yield
  • PACB N/A
  • CTO 9.25%
  • EPS Growth
  • PACB N/A
  • CTO N/A
  • EPS
  • PACB N/A
  • CTO N/A
  • Revenue
  • PACB $152,357,000.00
  • CTO $140,996,000.00
  • Revenue This Year
  • PACB $3.36
  • CTO $19.01
  • Revenue Next Year
  • PACB $18.20
  • CTO $7.38
  • P/E Ratio
  • PACB N/A
  • CTO N/A
  • Revenue Growth
  • PACB N/A
  • CTO 22.26
  • 52 Week Low
  • PACB $0.85
  • CTO $16.12
  • 52 Week High
  • PACB $2.72
  • CTO $21.15
  • Technical
  • Relative Strength Index (RSI)
  • PACB 47.27
  • CTO 36.63
  • Support Level
  • PACB $1.25
  • CTO $16.30
  • Resistance Level
  • PACB $1.44
  • CTO $16.78
  • Average True Range (ATR)
  • PACB 0.13
  • CTO 0.32
  • MACD
  • PACB -0.03
  • CTO -0.06
  • Stochastic Oscillator
  • PACB 21.57
  • CTO 11.67

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About CTO CTO Realty Growth Inc.

CTO Realty Growth Inc is a real estate investment trust company, that owns income properties comprised of approximately 2.7 million square feet in diversified markets in the United States. Its portfolio of assets consists of Income Properties Portfolio, management services, Commercial Loan and Investments.

Share on Social Networks: